A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Montefiore Sleep-Wake Disorders Center, The Bronx

Strong Sleep Disorders Center, Rochester

Parkinson's Disease Research Unit - Thomas Jefferson University, Philadelphia

Center for Sleep & Wake Disorders, Chevy Chase

SleepMed of South Carolina, Columbia

Bioclinica Research, Orlando

MD Clinical, Hallandale

QPS MRA (Miami Research Associates), Miami

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

PAB Clinical Research, Brandon

USF Health Byrd Institute, Tampa

Villages at Vanderbilt, Nashville

Clinical Neurophysiology Services, P.C., Sterling Heights

Henry Ford Medical Center - West Bloomfield, West Bloomfield

QUEST Research Institute, Farmington Hills

Rush University Medical Center, Chicago

St. Lukes Hospital Medical Center, Chesterfield

University of Kansas Medical Center Research Institute, Inc., Kansas City

Lynn Health Science Institute, Oklahoma City

Rocky Mountain Movement Disorders Center, PC, Englewood

Alpine Clinical Research Center, Boulder

Southern California Institute For Respiratory Diseases, Inc., Los Angeles

Pacific Research Network, Inc, San Diego

Evergreen Hospital Medical Center, Kirkland

Premier Clinical Research - Sherman, Spokane